RAC Ann: Zantrene AML trial in Israel advances to Phase 2 - 27th May 2022, 9:41am

annb0t

annb0t

Top 20
RAC Ann: Zantrene AML trial in Israel advances to Phase 2
Price Sensitive: Y
Date: 27th May 2022, 9:41am

>>> Read announcement: Google: RAC Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
RAC Ann: New Collaboration to Understand Zantrene Cardioprotection - 2nd Mar 2023, 12:33pm
Replies
0
Views
154
annb0t
annb0t
annb0t
RAC Ann: Positive Pre-IND Guidance from FDA on Zantrene - 23rd Nov 2022, 10:30am
Replies
0
Views
142
annb0t
annb0t
annb0t
RAC Ann: Race Develops Improved IV Formulation of Zantrene - 28th Sep 2022, 9:15am
Replies
0
Views
143
annb0t
annb0t
annb0t
RAC Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage - 30th Jun 2022, 9:17am
Replies
0
Views
193
annb0t
annb0t
annb0t
RAC Ann: Zantrene shows synergy with kinase inhibitors in melanoma - 28th Jun 2022, 9:07am
Replies
0
Views
186
annb0t
annb0t
Top Bottom